AQR Capital Management
PAHC icon

AQR Capital Management’s Phibro Animal Health PAHC Stock Holding History

AQR Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.18M Sell
57,518
-5,512
-9% -$262K ﹤0.01% 2049
2025
Q4 		$2.35M Sell
63,030
-26,138
-29% -$1.06M ﹤0.01% 2046
2025
Q3 		$3.61M Sell
89,168
-6,142
-6% -$203K ﹤0.01% 1642
2025
Q2 		$2.43M Sell
95,310
-86,764
-48% -$1.89M ﹤0.01% 1665
2025
Q1 		$3.89M Sell
182,074
-145,344
-44% -$3.25M ﹤0.01% 1252
2024
Q4 		$6.88M Buy
327,418
+71,150
+28% +$1.65M 0.01% 969
2024
Q3 		$5.77M Buy
256,268
+73,058
+40% +$1.41M 0.01% 984
2024
Q2 		$3.07M Buy
183,210
+4,700
+3% +$75.5K ﹤0.01% 1265
2024
Q1 		$2.31M Buy
+178,510
New +$2.14M ﹤0.01% 1351
2023
Q4 		– Sell
-100,302
Closed -$1.28M – 2416
2023
Q3 		$1.28M Sell
100,302
-140,699
-58% -$1.99M ﹤0.01% 1513
2023
Q2 		$3.3M Sell
241,001
-60,237
-20% -$863K 0.01% 1072
2023
Q1 		$4.61M Buy
301,238
+29,991
+11% +$458K 0.01% 923
2022
Q4 		$3.64M Buy
271,247
+139,958
+107% +$1.88M 0.01% 1023
2022
Q3 		$1.75M Buy
131,289
+96,155
+274% +$1.66M ﹤0.01% 1265
2022
Q2 		$672K Buy
35,134
+11,487
+49% +$218K ﹤0.01% 1572
2022
Q1 		$472K Buy
23,647
+2,738
+13% +$55.3K ﹤0.01% 1839
2021
Q4 		$427K Buy
20,909
+2,426
+13% +$51.8K ﹤0.01% 1872
2021
Q3 		$398K Sell
18,483
-2,785
-13% -$67K ﹤0.01% 1945
2021
Q2 		$614K Sell
21,268
-29,202
-58% -$790K ﹤0.01% 1815
2021
Q1 		$1.23M Sell
50,470
-30,707
-38% -$694K ﹤0.01% 1460
2020
Q4 		$1.58M Buy
81,177
+7,523
+10% +$138K ﹤0.01% 1291
2020
Q3 		$1.28M Sell
73,654
-17,281
-19% -$369K ﹤0.01% 1293
2020
Q2 		$2.39M Sell
90,935
-33,256
-27% -$826K ﹤0.01% 1081
2020
Q1 		$3M Sell
124,191
-4,024
-3% -$98.3K 0.01% 939
2019
Q4 		$3.18M Sell
128,215
-14,496
-10% -$336K ﹤0.01% 1102
2019
Q3 		$3.04M Sell
142,711
-20,670
-13% -$566K ﹤0.01% 1135
2019
Q2 		$5.19M Sell
163,381
-48,292
-23% -$1.51M 0.01% 966
2019
Q1 		$6.99M Buy
211,673
+5,613
+3% +$175K 0.01% 882
2018
Q4 		$6.63M Sell
206,060
-63,503
-24% -$2.4M 0.01% 854
2018
Q3 		$11.6M Sell
269,563
-4,770
-2% -$225K 0.01% 739
2018
Q2 		$12.6M Sell
274,333
-14,978
-5% -$663K 0.01% 715
2018
Q1 		$11.5M Sell
289,311
-19,468
-6% -$721K 0.01% 735
2017
Q4 		$10.3M Buy
308,779
+24,140
+8% +$857K 0.01% 778
2017
Q3 		$10.5M Buy
284,639
+134,887
+90% +$5.07M 0.01% 761
2017
Q2 		$5.55M Buy
149,752
+71,409
+91% +$2.33M 0.01% 988
2017
Q1 		$2.2M Buy
78,343
+26,244
+50% +$740K ﹤0.01% 1340
2016
Q4 		$1.53M Sell
52,099
-11,742
-18% -$320K ﹤0.01% 1535
2016
Q3 		$1.74M Buy
63,841
+21,105
+49% +$477K ﹤0.01% 1480
2016
Q2 		$798K Sell
42,736
-6,004
-12% -$125K ﹤0.01% 1693
2016
Q1 		$1.32M Sell
48,740
-25,863
-35% -$742K ﹤0.01% 1464
2015
Q4 		$2.25M Buy
74,603
+38,209
+105% +$1.23M ﹤0.01% 1189
2015
Q3 		$1.15M Buy
36,394
+17,941
+97% +$655K ﹤0.01% 1364
2015
Q2 		$719K Buy
+18,453
New +$637K ﹤0.01% 1648

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AQR Capital Management's PAHC Position: Q1 2026 in Review

AQR Capital Management reduced its Phibro Animal Health (PAHC) stake by 8.7% in Q1 2026, selling an estimated $262K and leaving 57,518 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

AQR Capital Management first reported a position in PAHC in Q2 2015 and has held it in 43 quarters since. The position peaked at $12.6M in Q2 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • AQR Capital Management held 57,518 shares of Phibro Animal Health worth $3.18M as of Q1 2026.
  • AQR Capital Management sold 5,512 Phibro Animal Health shares in Q1 2026, an estimated $262K.
  • Phibro Animal Health made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2049 holding.
  • AQR Capital Management first reported a position in Phibro Animal Health in Q2 2015 and has held it in 43 quarters since.
  • AQR Capital Management's Phibro Animal Health position peaked at $12.6M in Q2 2018.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.